Selected article for: "current study and IFN Î production"

Author: Pizzutto, Susan J.; Upham, John W.; Yerkovich, Stephanie T.; Chang, Anne B.
Title: High Pulmonary Levels of IL-6 and IL-1ß in Children with Chronic Suppurative Lung Disease Are Associated with Low Systemic IFN-? Production in Response to Non-Typeable Haemophilus influenzae
  • Document date: 2015_6_12
  • ID: 19jo817j_32
    Snippet: An alternative explanation for our finding regarding the association between increased local (BAL) inflammation and the poorer systemic adaptive response is that insufficient IFN-γ may contribute to increased susceptibility to infections with NTHi and subsequently a heightened state of local inflammation. There is increasing evidence to indicate that a strong systemic IFNγ response is associated with protective immunity against NTHi [5, 8] An i.....
    Document: An alternative explanation for our finding regarding the association between increased local (BAL) inflammation and the poorer systemic adaptive response is that insufficient IFN-γ may contribute to increased susceptibility to infections with NTHi and subsequently a heightened state of local inflammation. There is increasing evidence to indicate that a strong systemic IFNγ response is associated with protective immunity against NTHi [5, 8] An impaired ability to produce sufficient IFN-γ in response to a challenge by NTHi may lead to an increased susceptibility to respiratory infections and prolonged inflammation due to ineffective clearing mechanisms. While the current cross-sectional study has found no relation between NTHispecific IFN-γ production and severity of bronchiectasis, resolving this issue will require prospective studies examining the relationship between capacity for IFN-γ production and clinical outcomes.

    Search related documents:
    Co phrase search for related documents
    • adaptive response and clearing mechanism: 1
    • adaptive response and clinical outcome: 1, 2, 3, 4, 5, 6, 7
    • adaptive response and cross sectional study: 1, 2, 3
    • adaptive response and IFN γ: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adaptive response and IFN γ production: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • adaptive response and IFNγ response: 1, 2, 3, 4, 5, 6, 7
    • adaptive response and impaired ability: 1, 2, 3
    • adaptive response and increase susceptibility: 1, 2
    • adaptive response and local inflammation: 1, 2, 3, 4
    • alternative explanation and clinical outcome: 1
    • BAL inflammation and IFN γ: 1, 2
    • clinical outcome and cross sectional study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical outcome and IFN γ: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • clinical outcome and IFN γ production: 1, 2
    • clinical outcome and IFNγ response: 1, 2, 3, 4
    • clinical outcome and increase susceptibility: 1, 2
    • clinical outcome and local inflammation: 1, 2, 3, 4
    • cross sectional study and current cross sectional study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cross sectional study and IFN γ: 1, 2, 3, 4, 5, 6, 7, 8, 9